159 related articles for article (PubMed ID: 11389058)
1. Genetic alterations of candidate tumor suppressor ING1 in human esophageal squamous cell cancer.
Chen L; Matsubara N; Yoshino T; Nagasaka T; Hoshizima N; Shirakawa Y; Naomoto Y; Isozaki H; Riabowol K; Tanaka N
Cancer Res; 2001 Jun; 61(11):4345-9. PubMed ID: 11389058
[TBL] [Abstract][Full Text] [Related]
2. Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas.
Gunduz M; Ouchida M; Fukushima K; Hanafusa H; Etani T; Nishioka S; Nishizaki K; Shimizu K
Cancer Res; 2000 Jun; 60(12):3143-6. PubMed ID: 10866301
[TBL] [Abstract][Full Text] [Related]
3. Analyses of the tumour suppressor ING1 expression and gene mutation in human basal cell carcinoma.
Chen B; Campos EI; Crawford R; Martinka M; Li G
Int J Oncol; 2003 Apr; 22(4):927-31. PubMed ID: 12632089
[TBL] [Abstract][Full Text] [Related]
4. Genetic alterations of tumor suppressor ING1 in human non-small cell lung cancer.
Luo ZG; Tang H; Li B; Zhu Z; Ni CR; Zhu MH
Oncol Rep; 2011 Apr; 25(4):1073-81. PubMed ID: 21286670
[TBL] [Abstract][Full Text] [Related]
5. Suppression of ING1 expression in sporadic breast cancer.
Toyama T; Iwase H; Watson P; Muzik H; Saettler E; Magliocco A; DiFrancesco L; Forsyth P; Garkavtsev I; Kobayashi S; Riabowol K
Oncogene; 1999 Sep; 18(37):5187-93. PubMed ID: 10498868
[TBL] [Abstract][Full Text] [Related]
6. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors.
Vieyra D; Senger DL; Toyama T; Muzik H; Brasher PM; Johnston RN; Riabowol K; Forsyth PA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5952-61. PubMed ID: 14676120
[TBL] [Abstract][Full Text] [Related]
7. Mutations of the ING1 tumor suppressor gene detected in human melanoma abrogate nucleotide excision repair.
Campos EI; Martinka M; Mitchell DL; Dai DL; Li G
Int J Oncol; 2004 Jul; 25(1):73-80. PubMed ID: 15201991
[TBL] [Abstract][Full Text] [Related]
8. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
9. Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma.
Kuroki T; Trapasso F; Shiraishi T; Alder H; Mimori K; Mori M; Croce CM
Cancer Res; 2002 Apr; 62(8):2258-60. PubMed ID: 11956080
[TBL] [Abstract][Full Text] [Related]
10. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
[TBL] [Abstract][Full Text] [Related]
11. Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma.
Zhu C; Qin YR; Xie D; Chua DT; Fung JM; Chen L; Fu L; Hu L; Guan XY
Oncogene; 2009 Aug; 28(31):2821-8. PubMed ID: 19525977
[TBL] [Abstract][Full Text] [Related]
12. [Allelic loss and down-regulation of FHIT gene expression in esophageal squamous cell carcinoma].
Liu FX; Huang XP; Zhao CX; Xu X; Han YL; Cai Y; Wu RL; Wu M; Zhan QM; Wang MR
Ai Zheng; 2004 Sep; 23(9):992-8. PubMed ID: 15363189
[TBL] [Abstract][Full Text] [Related]
13. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.
Gunduz M; Nagatsuka H; Demircan K; Gunduz E; Cengiz B; Ouchida M; Tsujigiwa H; Yamachika E; Fukushima K; Beder L; Hirohata S; Ninomiya Y; Nishizaki K; Shimizu K; Nagai N
Gene; 2005 Aug; 356():109-17. PubMed ID: 15935570
[TBL] [Abstract][Full Text] [Related]
14. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
Hu YC; Lam KY; Law S; Wong J; Srivastava G
Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
[TBL] [Abstract][Full Text] [Related]
15. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.
Jäger D; Stockert E; Scanlan MJ; Güre AO; Jäger E; Knuth A; Old LJ; Chen YT
Cancer Res; 1999 Dec; 59(24):6197-204. PubMed ID: 10626813
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of the candidate tumor suppressor gene ING1 is associated with poor prognosis in advanced neuroblastomas.
Takahashi M; Ozaki T; Todo S; Nakagawara A
Oncol Rep; 2004 Oct; 12(4):811-6. PubMed ID: 15375504
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma.
Hu N; Flaig MJ; Su H; Shou JZ; Roth MJ; Li WJ; Wang C; Goldstein AM; Li G; Emmert-Buck MR; Taylor PR
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6013-22. PubMed ID: 15447985
[TBL] [Abstract][Full Text] [Related]
18. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers.
Gunduz M; Ouchida M; Fukushima K; Ito S; Jitsumori Y; Nakashima T; Nagai N; Nishizaki K; Shimizu K
Oncogene; 2002 Jun; 21(28):4462-70. PubMed ID: 12080476
[TBL] [Abstract][Full Text] [Related]
19. The tumor suppressor candidate p33(ING1) mediates repair of UV-damaged DNA.
Cheung KJ; Mitchell D; Lin P; Li G
Cancer Res; 2001 Jul; 61(13):4974-7. PubMed ID: 11431327
[TBL] [Abstract][Full Text] [Related]
20. Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China.
Hu N; Huang J; Emmert-Buck MR; Tang ZZ; Roth MJ; Wang C; Dawsey SM; Li G; Li WJ; Wang QH; Han XY; Ding T; Giffen C; Goldstein AM; Taylor PR
Clin Cancer Res; 2001 Apr; 7(4):883-91. PubMed ID: 11309337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
